Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Nephrotoxicity is a major side effect of cisplatin, a widely used cancer therapy drug. Depending on its concentration, cisplatin induces necrosis or apoptosis of tubular cells in the kidneys, whereas the underlying injury mechanism is unclear. Our recent work has suggested a critical role for p53 in cisplatin-induced tubular cell apoptosis; nevertheless, the apoptotic events triggered by p53 remain elusive. The current study has examined Bcl-2 family proteins, critical regulators of apoptosis that may be subjected to p53 regulation. Following cisplatin treatment, the expression of Bcl-xL, an antiapoptotic molecule, was suppressed, while the expression of Bak, a proapoptotic molecule, increased slightly. Of interest, PUMA-α, a newly identified p53-responsive proapoptotic Bcl-2 family protein, was drastically induced by cisplatin. PUMA-α induction preceded or paralleled the development of apoptosis. Induced PUMA-α was localized in mitochondria and appeared to antagonize Bcl-xL via molecular interaction. PUMA-α induction during cisplatin treatment was attenuated by pifithrin-α, a pharmacological inhibitor of p53, which was accompanied by the amelioration of Bax activation, cytochrome c release and apoptosis. Moreover, PUMA-α induction was suppressed by dominant-negative p53. Importantly, cisplatin-induced apoptosis was ameliorated in PUMA-α knockout cells. In vivo, cisplatin induced PUMA-α in the kidneys, and the inductive response was abrogated in p53-deficient animals. Together, this study has demonstrated the first compelling evidence for the involvement of PUMA-α in p53-mediated renal cell apoptosis during cisplatin nephrotoxicity.

Original languageEnglish (US)
Pages (from-to)4056-4066
Number of pages11
JournalOncogene
Volume25
Issue number29
DOIs
StatePublished - Jul 6 2006

Fingerprint

Cisplatin
Apoptosis
Kidney
Cytochromes c
Mitochondria
Proteins
Necrosis
Pharmacology
Drug Therapy
Wounds and Injuries
Therapeutics
Neoplasms

Keywords

  • Apoptosis
  • Cisplatin
  • Mitochondria
  • Nephrotoxicity
  • PUMA
  • p53

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis. / Livingston, Man Jiang; Wei, QingQing; Wang, J.; Du, Quansheng; Yu, J.; Zhang, L.; Dong, Zheng.

In: Oncogene, Vol. 25, No. 29, 06.07.2006, p. 4056-4066.

Research output: Contribution to journalArticle

@article{638c61f46a604c2880248243c07e4eb3,
title = "Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis",
abstract = "Nephrotoxicity is a major side effect of cisplatin, a widely used cancer therapy drug. Depending on its concentration, cisplatin induces necrosis or apoptosis of tubular cells in the kidneys, whereas the underlying injury mechanism is unclear. Our recent work has suggested a critical role for p53 in cisplatin-induced tubular cell apoptosis; nevertheless, the apoptotic events triggered by p53 remain elusive. The current study has examined Bcl-2 family proteins, critical regulators of apoptosis that may be subjected to p53 regulation. Following cisplatin treatment, the expression of Bcl-xL, an antiapoptotic molecule, was suppressed, while the expression of Bak, a proapoptotic molecule, increased slightly. Of interest, PUMA-α, a newly identified p53-responsive proapoptotic Bcl-2 family protein, was drastically induced by cisplatin. PUMA-α induction preceded or paralleled the development of apoptosis. Induced PUMA-α was localized in mitochondria and appeared to antagonize Bcl-xL via molecular interaction. PUMA-α induction during cisplatin treatment was attenuated by pifithrin-α, a pharmacological inhibitor of p53, which was accompanied by the amelioration of Bax activation, cytochrome c release and apoptosis. Moreover, PUMA-α induction was suppressed by dominant-negative p53. Importantly, cisplatin-induced apoptosis was ameliorated in PUMA-α knockout cells. In vivo, cisplatin induced PUMA-α in the kidneys, and the inductive response was abrogated in p53-deficient animals. Together, this study has demonstrated the first compelling evidence for the involvement of PUMA-α in p53-mediated renal cell apoptosis during cisplatin nephrotoxicity.",
keywords = "Apoptosis, Cisplatin, Mitochondria, Nephrotoxicity, PUMA, p53",
author = "Livingston, {Man Jiang} and QingQing Wei and J. Wang and Quansheng Du and J. Yu and L. Zhang and Zheng Dong",
year = "2006",
month = "7",
day = "6",
doi = "10.1038/sj.onc.1209440",
language = "English (US)",
volume = "25",
pages = "4056--4066",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "29",

}

TY - JOUR

T1 - Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis

AU - Livingston, Man Jiang

AU - Wei, QingQing

AU - Wang, J.

AU - Du, Quansheng

AU - Yu, J.

AU - Zhang, L.

AU - Dong, Zheng

PY - 2006/7/6

Y1 - 2006/7/6

N2 - Nephrotoxicity is a major side effect of cisplatin, a widely used cancer therapy drug. Depending on its concentration, cisplatin induces necrosis or apoptosis of tubular cells in the kidneys, whereas the underlying injury mechanism is unclear. Our recent work has suggested a critical role for p53 in cisplatin-induced tubular cell apoptosis; nevertheless, the apoptotic events triggered by p53 remain elusive. The current study has examined Bcl-2 family proteins, critical regulators of apoptosis that may be subjected to p53 regulation. Following cisplatin treatment, the expression of Bcl-xL, an antiapoptotic molecule, was suppressed, while the expression of Bak, a proapoptotic molecule, increased slightly. Of interest, PUMA-α, a newly identified p53-responsive proapoptotic Bcl-2 family protein, was drastically induced by cisplatin. PUMA-α induction preceded or paralleled the development of apoptosis. Induced PUMA-α was localized in mitochondria and appeared to antagonize Bcl-xL via molecular interaction. PUMA-α induction during cisplatin treatment was attenuated by pifithrin-α, a pharmacological inhibitor of p53, which was accompanied by the amelioration of Bax activation, cytochrome c release and apoptosis. Moreover, PUMA-α induction was suppressed by dominant-negative p53. Importantly, cisplatin-induced apoptosis was ameliorated in PUMA-α knockout cells. In vivo, cisplatin induced PUMA-α in the kidneys, and the inductive response was abrogated in p53-deficient animals. Together, this study has demonstrated the first compelling evidence for the involvement of PUMA-α in p53-mediated renal cell apoptosis during cisplatin nephrotoxicity.

AB - Nephrotoxicity is a major side effect of cisplatin, a widely used cancer therapy drug. Depending on its concentration, cisplatin induces necrosis or apoptosis of tubular cells in the kidneys, whereas the underlying injury mechanism is unclear. Our recent work has suggested a critical role for p53 in cisplatin-induced tubular cell apoptosis; nevertheless, the apoptotic events triggered by p53 remain elusive. The current study has examined Bcl-2 family proteins, critical regulators of apoptosis that may be subjected to p53 regulation. Following cisplatin treatment, the expression of Bcl-xL, an antiapoptotic molecule, was suppressed, while the expression of Bak, a proapoptotic molecule, increased slightly. Of interest, PUMA-α, a newly identified p53-responsive proapoptotic Bcl-2 family protein, was drastically induced by cisplatin. PUMA-α induction preceded or paralleled the development of apoptosis. Induced PUMA-α was localized in mitochondria and appeared to antagonize Bcl-xL via molecular interaction. PUMA-α induction during cisplatin treatment was attenuated by pifithrin-α, a pharmacological inhibitor of p53, which was accompanied by the amelioration of Bax activation, cytochrome c release and apoptosis. Moreover, PUMA-α induction was suppressed by dominant-negative p53. Importantly, cisplatin-induced apoptosis was ameliorated in PUMA-α knockout cells. In vivo, cisplatin induced PUMA-α in the kidneys, and the inductive response was abrogated in p53-deficient animals. Together, this study has demonstrated the first compelling evidence for the involvement of PUMA-α in p53-mediated renal cell apoptosis during cisplatin nephrotoxicity.

KW - Apoptosis

KW - Cisplatin

KW - Mitochondria

KW - Nephrotoxicity

KW - PUMA

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=33745778238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745778238&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209440

DO - 10.1038/sj.onc.1209440

M3 - Article

C2 - 16491117

AN - SCOPUS:33745778238

VL - 25

SP - 4056

EP - 4066

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 29

ER -